(Boston, MA, April 13, 2016) – The Clinton Health Access Initiative, Inc. (CHAI) and AmeriCares, with the aid of a multi-year product-donation from Bristol-Myers Squibb, have initiated a first-of-its-kind program in Africa and Asia aimed at curing hepatitis C (HCV)...
The IKEA Foundation and the Clinton Health Access Initiative, Inc. (CHAI) announce a new four-year grant, which commenced in January 2016, aimed at improving nutritional outcomes and child health in Madhya Pradesh, India. “The IKEA Foundation believes that every child...
By the end of 2015, diarrhea remained a leading killer of children under 5. However, important progress has been made to scale up zinc and oral rehydration salts (ORS), which together are the recommended treatment for childhood diarrhea. Since the release of the...
For Immediate Release Contact: press@clintonhealthaccess.org Becton Dickinson partners with the Clinton Health Access Initiative, Inc. (CHAI) to implement an innovative CD4 Access Solution Rethinking the Role of Diagnostics Suppliers in Public Health 18 December 2015...
These agreements have the potential to increase access to state-of-the-art HIV treatment regimens for people living with HIV in low- and middle- income countries.
Universal health coverage (UHC) cannot be realized without an adequate health workforce and in particular community health workers (CHW) can make a considerable contribution towards achieving UHC. The Government of Zambia has recognized this and to improve access to...
The Clinton Health Access Initiative, Inc. (CHAI) and the Ministry of Health of Zambia announce the release of new evidence regarding the integration of infant HIV testing with routine immunization services. Early testing of HIV-exposed infants and the initiation of...
The 2014 Annual Report highlights CHAI's programmatic work around the world, thanks to our many dedicated partners and supporters. [button link="http://4flgro3ji5k53a1sca42s7hm.wpengine.netdna-cdn.com/wp-content/uploads/2015/08/CHAI-2014-Annual-Report.pdf" color="red"...
CHAI and global partners in the Diagnostics Access Initiative have joined with Roche Diagnostics to announce a 35 percent reduction in the price for HIV early infant diagnostic technologies. The new access price is US$9.40 per test, including proprietary reagents and...
ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV London, May 26, 2015 - ViiV Healthcare, Aurobindo Pharma, and the Clinton Health Access Initiative,...
